Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Contents - page 173
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial67
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study63
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France59
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report45
Editorial board42
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department41
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement38
Contents35
Editorial board35
Massive lactic acidosis and ketoacidosis with glucagon deficiency in a chronic alcoholic patient33
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients32
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes31
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood31
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort30
Association between adipose deposition and mortality among adults without major cardiovascular risk factors30
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review28
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”28
Editorial board28
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202027
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes27
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis27
Concise review of lipidomics in nonalcoholic fatty liver disease26
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes26
Sommaire24
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202124
Editorial board24
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes24
Contents24
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?24
Could metformin modulate cardiovascular outcomes differently with DPP-4 inhibitors compared with SGLT2 inhibitors?23
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study22
1-h post-load plasma glucose for detecting early stages of prediabetes22
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability21
Type B insulin resistance syndrome: A case report20
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-201820
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY319
Comment on Gaudillère et al. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme [Diabetes Metab 2021 Apr 13; 101251]19
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”19
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin18
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes18
Averaged glycaemic variability or by average: More than a simple question of wording18
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT17
Methylamine metabolites and progression to kidney failure in type 2 diabetes: an Asian and European prospective study17
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications17
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study17
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease16
Editorial board16
Editorial board16
Contents - Page 116
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study15
Transitions in metabolic health status over time and risk of heart failure: A prospective study15
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction15
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention15
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations15
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach15
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus14
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes14
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies14
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation14
Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure13
Contents13
Contents - page 113
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy12
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance12
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design11
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease11
Glucagon like peptide-1 receptor agonists in type 1 diabetes11
Contents11
Editorial board11
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand11
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders10
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis10
Diabetic ketoacidosis and mortality in COVID-19 infection10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study10
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs10
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults10
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION9
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States9
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus9
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan9
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 20198
Editorial board8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus8
Editorial board8
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch8
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study8
Glycaemic variabilities: Key questions in pursuit of clarity8
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists8
The progressive uncoupling of maternal insulin clearance and insulin sensitivity across gestation8
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?8
0.03711199760437